A Phase IV Study of Iguratimod in Patients With Active Rheumatoid Arthritis (RA)
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Iguratimod (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Jiangsu Simcere Pharmaceutical
- 22 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 18 May 2012 Actual initiation date May 2012 added as reported by ClinicalTrials.gov.